Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Janet Rader

Concepts (656)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Uterine Cervical Neoplasms
85
2025
301
11.960
Why?
Ovarian Neoplasms
38
2025
459
2.760
Why?
Papillomavirus Infections
19
2025
177
2.700
Why?
Endometrial Neoplasms
34
2019
143
2.210
Why?
Uterine Cervical Dysplasia
16
2017
51
2.190
Why?
Carcinoma, Squamous Cell
31
2018
332
1.860
Why?
Gene Expression Regulation, Neoplastic
19
2025
868
1.770
Why?
Human papillomavirus 16
8
2019
44
1.570
Why?
Papillomaviridae
17
2025
104
1.480
Why?
Female
193
2026
28792
1.470
Why?
Gene Expression Profiling
9
2021
1112
1.400
Why?
Antineoplastic Combined Chemotherapy Protocols
18
2025
1043
1.340
Why?
DNA Methylation
22
2025
592
1.220
Why?
Humans
196
2026
53246
1.090
Why?
Genital Neoplasms, Female
10
2018
48
1.090
Why?
Human papillomavirus 18
5
2019
9
1.070
Why?
Genetic Predisposition to Disease
14
2024
533
1.030
Why?
Adult
92
2024
14541
0.980
Why?
Neoplasm Staging
41
2019
774
0.950
Why?
Middle Aged
99
2024
13422
0.930
Why?
Adenocarcinoma
18
2018
405
0.920
Why?
Polymorphism, Single Nucleotide
10
2019
505
0.890
Why?
Fluorodeoxyglucose F18
15
2022
182
0.880
Why?
DNA-Binding Proteins
9
2021
423
0.870
Why?
Neoplasm Recurrence, Local
19
2024
647
0.860
Why?
MicroRNAs
7
2019
397
0.850
Why?
Carcinoma
12
2010
136
0.830
Why?
Genomics
5
2026
271
0.780
Why?
Oncogene Proteins, Viral
4
2019
52
0.780
Why?
Radiopharmaceuticals
14
2022
198
0.730
Why?
Repressor Proteins
4
2019
149
0.730
Why?
Cervix Uteri
7
2017
43
0.730
Why?
Cell Line, Tumor
19
2025
1470
0.710
Why?
Alphapapillomavirus
1
2021
14
0.690
Why?
DNA, Viral
6
2019
136
0.670
Why?
Granulosa Cell Tumor
3
2025
4
0.650
Why?
Immunologic Factors
2
2014
117
0.650
Why?
Neoplasm Invasiveness
15
2020
281
0.630
Why?
Neoplasms
8
2022
1335
0.620
Why?
Genetic Markers
8
2017
104
0.610
Why?
Genes, Tumor Suppressor
8
2007
73
0.610
Why?
Neoplasm Proteins
10
2019
330
0.600
Why?
Aged
70
2024
10430
0.600
Why?
Immunoglobulins
3
2017
76
0.600
Why?
Biomedical Research
1
2022
267
0.560
Why?
Gene Silencing
5
2018
122
0.560
Why?
Vascular Endothelial Growth Factor A
2
2017
189
0.510
Why?
Cisplatin
7
2022
282
0.500
Why?
Proteomics
1
2019
337
0.500
Why?
Promoter Regions, Genetic
12
2020
465
0.480
Why?
Aged, 80 and over
36
2024
3495
0.480
Why?
HLA-C Antigens
2
2018
5
0.470
Why?
Receptors, KIR
2
2018
11
0.470
Why?
Positron-Emission Tomography
11
2013
299
0.460
Why?
Lymph Nodes
10
2010
252
0.450
Why?
Ubiquitin Thiolesterase
2
2021
17
0.450
Why?
Tumor Virus Infections
4
2006
46
0.450
Why?
Alleles
6
2025
277
0.450
Why?
Microsatellite Repeats
14
2007
41
0.450
Why?
Disease-Free Survival
17
2013
466
0.440
Why?
Hysterectomy
15
2022
91
0.440
Why?
Gynecologic Surgical Procedures
4
2010
29
0.440
Why?
Virus Integration
3
2025
9
0.430
Why?
Phenotype
5
2016
803
0.420
Why?
Prognosis
19
2021
2118
0.410
Why?
Lymphatic Metastasis
14
2019
211
0.410
Why?
Immunohistochemistry
13
2024
975
0.400
Why?
Chromosomes, Human, Pair 6
4
2007
15
0.400
Why?
Nuclear Proteins
8
2009
250
0.390
Why?
Loss of Heterozygosity
10
2007
78
0.390
Why?
Cell Proliferation
7
2025
1031
0.390
Why?
Ovary
2
2008
103
0.370
Why?
Membrane Proteins
3
2005
333
0.370
Why?
Genotype
9
2018
563
0.360
Why?
Survival Analysis
14
2021
659
0.360
Why?
STAT3 Transcription Factor
3
2021
89
0.360
Why?
Cell Movement
5
2021
279
0.360
Why?
Ultrasonic Therapy
3
2001
30
0.350
Why?
Peritoneal Neoplasms
4
2008
68
0.350
Why?
Carcinoma, Endometrioid
6
2014
38
0.350
Why?
Genes, p53
2
2010
51
0.340
Why?
Risk Factors
13
2019
4018
0.330
Why?
Signal Transduction
8
2021
1748
0.330
Why?
Uterine Neoplasms
5
2009
57
0.330
Why?
Mutation
12
2018
1338
0.330
Why?
Antibodies, Monoclonal
5
2021
477
0.320
Why?
Ascites
2
2008
31
0.320
Why?
Carboplatin
2
2009
57
0.320
Why?
Antineoplastic Agents
9
2014
1232
0.320
Why?
NAD(P)H Dehydrogenase (Quinone)
1
2010
11
0.310
Why?
Proto-Oncogene Proteins c-mdm2
1
2010
15
0.310
Why?
Cohort Studies
13
2024
1557
0.310
Why?
Base Sequence
8
2019
620
0.310
Why?
Membrane Glycoproteins
2
2009
238
0.310
Why?
Disease Progression
6
2020
880
0.310
Why?
GTPase-Activating Proteins
1
2009
25
0.310
Why?
DNA, Neoplasm
11
2006
146
0.300
Why?
Matrix Metalloproteinase 9
1
2009
88
0.300
Why?
Chromosomes, Human, Pair 11
3
2005
56
0.300
Why?
Neoplasms, Glandular and Epithelial
3
2006
42
0.290
Why?
Combined Modality Therapy
11
2010
640
0.290
Why?
Brachytherapy
9
2014
51
0.290
Why?
Abdominal Neoplasms
1
2009
16
0.290
Why?
Proto-Oncogene Proteins c-myc
2
2021
55
0.290
Why?
Genome, Human
3
2025
121
0.290
Why?
Laser Coagulation
1
2009
26
0.280
Why?
DNA Repair
11
2007
197
0.280
Why?
Retrospective Studies
33
2024
6821
0.280
Why?
Drug Administration Schedule
10
2013
370
0.280
Why?
Homeodomain Proteins
2
2006
81
0.280
Why?
Deoxycytidine
4
2006
26
0.280
Why?
RNA-Binding Proteins
2
2021
133
0.270
Why?
Laparoscopy
3
2022
180
0.270
Why?
Protozoan Proteins
1
2008
33
0.270
Why?
Microsatellite Instability
5
2019
21
0.270
Why?
Germ-Line Mutation
3
2024
67
0.270
Why?
Kaplan-Meier Estimate
6
2019
487
0.270
Why?
Ovariectomy
7
2010
114
0.260
Why?
Antigens, CD
2
2007
217
0.260
Why?
Breast Neoplasms
6
2026
1223
0.260
Why?
Heart Arrest
1
2009
144
0.250
Why?
Drug Resistance, Neoplasm
6
2016
350
0.250
Why?
Polymerase Chain Reaction
9
2010
452
0.250
Why?
Chromosomes, Human, Pair 3
4
2001
18
0.250
Why?
SOXC Transcription Factors
2
2019
13
0.250
Why?
Receptors, Estrogen
3
2024
134
0.250
Why?
Topotecan
5
2013
17
0.240
Why?
POU Domain Factors
1
2006
1
0.240
Why?
Oligonucleotide Array Sequence Analysis
5
2010
412
0.240
Why?
Vulvar Neoplasms
5
2002
61
0.240
Why?
Neoplasm Metastasis
5
2021
237
0.240
Why?
HeLa Cells
3
2021
243
0.240
Why?
Registries
6
2010
652
0.230
Why?
Genome, Viral
2
2025
78
0.230
Why?
Anemia
3
2020
76
0.230
Why?
Survival Rate
10
2009
949
0.230
Why?
Antineoplastic Agents, Hormonal
1
2025
56
0.220
Why?
Vaginal Smears
6
2006
28
0.220
Why?
Breast
1
2026
87
0.220
Why?
Young Adult
7
2018
4514
0.220
Why?
Reverse Transcriptase Polymerase Chain Reaction
4
2007
579
0.210
Why?
Gene Rearrangement
1
2025
76
0.210
Why?
Chromosome Aberrations
1
2006
297
0.210
Why?
HSP70 Heat-Shock Proteins
1
2004
71
0.200
Why?
Receptors, Androgen
1
2024
48
0.200
Why?
Receptors, Progesterone
1
2024
68
0.200
Why?
Cystadenocarcinoma, Papillary
2
2002
14
0.200
Why?
Oxidoreductases Acting on CH-NH Group Donors
1
2003
16
0.200
Why?
Oncostatin M
2
2021
5
0.200
Why?
Quinazolines
1
2003
34
0.200
Why?
Antigens, Neoplasm
1
2004
146
0.200
Why?
Polymorphism, Genetic
5
2018
181
0.190
Why?
Genome-Wide Association Study
2
2017
184
0.190
Why?
Small Cell Lung Carcinoma
1
2023
30
0.190
Why?
Case-Control Studies
7
2019
1212
0.190
Why?
Omentum
1
2002
16
0.190
Why?
Treatment Outcome
23
2014
5597
0.190
Why?
Chromosome Deletion
3
2000
138
0.190
Why?
Neoadjuvant Therapy
2
2022
124
0.180
Why?
Linkage Disequilibrium
3
2017
41
0.180
Why?
Proto-Oncogene Proteins c-akt
2
2014
171
0.180
Why?
Genetic Variation
4
2019
223
0.180
Why?
Antibodies, Monoclonal, Humanized
5
2013
238
0.180
Why?
Eukaryotic Initiation Factor-4F
1
2021
1
0.180
Why?
CA-125 Antigen
3
2008
16
0.180
Why?
Base Pair Mismatch
5
2006
20
0.180
Why?
Suction
1
2001
22
0.170
Why?
Chemoradiotherapy
1
2022
50
0.170
Why?
Tumor Microenvironment
2
2021
274
0.170
Why?
Postoperative Complications
3
2022
1099
0.170
Why?
Oncostatin M Receptor beta Subunit
1
2021
1
0.170
Why?
Smoking
1
2005
526
0.170
Why?
Proteins
5
2008
351
0.170
Why?
Radiotherapy, Conformal
2
2014
51
0.170
Why?
Carcinoma in Situ
2
2013
72
0.170
Why?
Adaptor Proteins, Signal Transducing
8
2007
202
0.170
Why?
Antimetabolites, Antineoplastic
2
2002
39
0.160
Why?
Minority Groups
1
2022
136
0.160
Why?
Radiotherapy
3
2010
126
0.160
Why?
Gene Regulatory Networks
2
2019
112
0.160
Why?
Fetofetal Transfusion
1
2020
5
0.160
Why?
Pregnancy, Twin
1
2020
7
0.160
Why?
Polycythemia
1
2020
10
0.160
Why?
Twins, Monozygotic
1
2020
15
0.160
Why?
Colorectal Neoplasms
3
2002
302
0.160
Why?
Lymph Node Excision
7
2019
132
0.160
Why?
Sarcoma
3
2009
72
0.160
Why?
Genetic Diseases, Inborn
1
2000
23
0.160
Why?
Patient Satisfaction
2
2006
292
0.160
Why?
Receptor, erbB-3
1
2020
2
0.160
Why?
Furin
1
2020
3
0.160
Why?
Phosphoproteins
2
2016
117
0.160
Why?
HLA-DQ Antigens
1
2000
3
0.160
Why?
Transcriptome
2
2020
368
0.160
Why?
Receptor, IGF Type 1
1
2020
21
0.160
Why?
Tomography, X-Ray Computed
7
2013
1183
0.150
Why?
Mice, Nude
4
2021
232
0.150
Why?
Prenatal Diagnosis
1
2020
94
0.150
Why?
Tumor Cells, Cultured
7
2021
441
0.150
Why?
RNA, Neoplasm
3
2007
45
0.150
Why?
Antibodies, Neoplasm
1
2019
27
0.150
Why?
Students
1
2022
249
0.150
Why?
Papillomavirus E7 Proteins
2
2017
30
0.150
Why?
Adolescent
13
2018
6912
0.150
Why?
Reproducibility of Results
2
2022
1221
0.150
Why?
NM23 Nucleoside Diphosphate Kinases
1
2019
4
0.150
Why?
Placenta
1
2020
146
0.140
Why?
Follow-Up Studies
13
2019
2318
0.140
Why?
Indocyanine Green
1
2019
29
0.140
Why?
Doxorubicin
4
2009
248
0.140
Why?
Decision Making
1
2001
278
0.140
Why?
Fallopian Tube Neoplasms
3
2008
15
0.140
Why?
Salvage Therapy
3
2008
138
0.140
Why?
Cyclooxygenase 2
2
2017
49
0.140
Why?
Transcription Factors
1
2021
571
0.130
Why?
Sequence Analysis, DNA
1
2019
216
0.130
Why?
Lung Neoplasms
2
2023
645
0.130
Why?
Metabolic Networks and Pathways
1
2018
90
0.130
Why?
HLA-DRB1 Chains
1
2017
6
0.130
Why?
HLA-B Antigens
1
2017
8
0.130
Why?
DNA Copy Number Variations
1
2018
117
0.130
Why?
Proto-Oncogene Proteins
5
2004
150
0.130
Why?
Tumor Suppressor Proteins
3
2005
130
0.130
Why?
Receptors, Vitronectin
1
1997
1
0.130
Why?
DNA Mutational Analysis
9
2005
179
0.130
Why?
Carcinoma, Adenosquamous
3
2009
9
0.130
Why?
Interleukin-10
1
2017
81
0.130
Why?
Animals
11
2021
13528
0.130
Why?
Bayes Theorem
1
2017
121
0.130
Why?
Leukocytes, Mononuclear
1
2017
122
0.130
Why?
Protein Binding
1
2019
670
0.130
Why?
Cyclooxygenase 2 Inhibitors
1
2017
22
0.130
Why?
In Situ Hybridization
3
2008
69
0.130
Why?
Radiotherapy, Intensity-Modulated
2
2009
181
0.120
Why?
Adipose Tissue
1
2019
210
0.120
Why?
Gene Expression Regulation, Viral
1
2017
49
0.120
Why?
Risk Assessment
9
2019
1368
0.120
Why?
Radiotherapy Dosage
8
2014
249
0.120
Why?
Body Mass Index
3
2010
717
0.120
Why?
Diagnosis, Differential
4
2024
1038
0.120
Why?
Radiation Injuries
3
2008
114
0.120
Why?
ROC Curve
1
2017
246
0.120
Why?
Taxoids
3
2006
38
0.120
Why?
Biopsy
5
2006
600
0.120
Why?
Prospective Studies
10
2019
2412
0.120
Why?
Cells, Cultured
3
2017
1569
0.120
Why?
Carrier Proteins
7
2006
315
0.120
Why?
Estrogens
1
2017
224
0.120
Why?
Molecular Sequence Data
5
2009
759
0.120
Why?
Colposcopy
3
2006
17
0.110
Why?
Mice
7
2021
5982
0.110
Why?
Wound Healing
2
2018
226
0.110
Why?
Apoptosis
2
2021
1139
0.110
Why?
Carcinosarcoma
3
2019
18
0.110
Why?
Sensitivity and Specificity
4
2006
869
0.110
Why?
Double-Blind Method
1
2017
729
0.110
Why?
Dose-Response Relationship, Drug
6
2008
1367
0.110
Why?
Algorithms
1
2019
668
0.110
Why?
Ultrasonography, Doppler, Color
1
1995
30
0.110
Why?
Aneurysm
1
1995
32
0.110
Why?
DNA Primers
2
2006
202
0.110
Why?
Protein Kinase Inhibitors
2
2014
234
0.110
Why?
Platinum Compounds
4
2008
10
0.110
Why?
Phosphatidylinositol 3-Kinases
2
2014
148
0.110
Why?
Obesity
5
2010
1205
0.110
Why?
Heterocyclic Compounds, 3-Ring
1
2014
5
0.100
Why?
Cyclohexanones
1
2014
4
0.100
Why?
Colorectal Neoplasms, Hereditary Nonpolyposis
2
2004
12
0.100
Why?
Embolization, Therapeutic
1
1995
91
0.100
Why?
Transcriptional Activation
2
2019
128
0.100
Why?
TOR Serine-Threonine Kinases
1
2014
83
0.100
Why?
Camptothecin
3
2010
14
0.100
Why?
Genetic Association Studies
1
2014
124
0.100
Why?
Hypercalcemia
1
1993
34
0.100
Why?
Introns
1
2013
51
0.100
Why?
Paclitaxel
4
2007
91
0.100
Why?
Decision Support Techniques
2
2010
73
0.100
Why?
Chromosome Mapping
3
2005
145
0.100
Why?
Cell Transformation, Neoplastic
2
2006
187
0.090
Why?
Pyridines
1
2014
135
0.090
Why?
Dermatologic Surgical Procedures
1
1992
35
0.090
Why?
Brain Neoplasms
1
2016
319
0.090
Why?
Models, Genetic
1
2012
169
0.090
Why?
Tomography, Emission-Computed
4
2005
53
0.090
Why?
Keratinocytes
2
2006
91
0.090
Why?
Groin
2
2002
16
0.090
Why?
RNA, Messenger
4
2021
1133
0.090
Why?
Laser Therapy
1
1992
75
0.090
Why?
Glucose
1
2014
361
0.090
Why?
Cystadenocarcinoma, Serous
2
2024
73
0.090
Why?
Exons
3
2007
100
0.090
Why?
Magnetic Resonance Imaging
3
2014
1587
0.090
Why?
Infusions, Intravenous
4
2006
211
0.090
Why?
Pyrazoles
2
2023
123
0.090
Why?
Models, Statistical
1
2012
229
0.080
Why?
Heterozygote
2
2004
89
0.080
Why?
Condylomata Acuminata
1
1991
5
0.080
Why?
Epithelium
2
2007
64
0.080
Why?
Goserelin
1
2010
1
0.080
Why?
Decision Trees
1
2010
23
0.080
Why?
Estrogen Antagonists
1
2010
21
0.080
Why?
Predictive Value of Tests
6
2010
933
0.080
Why?
Ileal Diseases
1
1990
4
0.080
Why?
Leiomyoma
1
1990
21
0.080
Why?
Cell Differentiation
2
2009
681
0.080
Why?
Polymorphism, Restriction Fragment Length
1
2010
65
0.080
Why?
Epigenesis, Genetic
2
2019
412
0.080
Why?
Restriction Mapping
3
2006
32
0.080
Why?
Colonic Neoplasms
2
2004
162
0.080
Why?
Gastrointestinal Hemorrhage
1
1990
91
0.080
Why?
Skin Transplantation
1
1990
43
0.080
Why?
Down-Regulation
4
2020
344
0.080
Why?
Age Factors
4
2006
1136
0.080
Why?
Fluorouracil
2
2006
59
0.070
Why?
Maximum Tolerated Dose
5
2010
42
0.070
Why?
Endometrium
3
2019
43
0.070
Why?
Urinary Bladder Diseases
1
2009
18
0.070
Why?
Intestinal Diseases
1
2009
25
0.070
Why?
Embolism, Air
1
2009
8
0.070
Why?
Lasers, Gas
1
2009
6
0.070
Why?
Lymphatic Vessels
1
2009
45
0.070
Why?
Transcription, Genetic
4
2019
374
0.070
Why?
Vaginal Neoplasms
2
2005
5
0.070
Why?
Adenocarcinoma, Clear Cell
3
2019
35
0.070
Why?
Fluorine Radioisotopes
1
2008
25
0.070
Why?
Primary Ovarian Insufficiency
1
2008
4
0.070
Why?
Infertility, Female
1
2008
18
0.070
Why?
Eimeria
1
2008
3
0.070
Why?
Haplotypes
2
2017
96
0.070
Why?
Up-Regulation
2
2020
456
0.070
Why?
Polyethylene Glycols
2
2006
95
0.070
Why?
Cell Cycle Proteins
1
2009
170
0.070
Why?
Angiogenesis Inhibitors
2
2006
186
0.070
Why?
Tumor Burden
2
2021
132
0.070
Why?
Cricetinae
1
2008
190
0.070
Why?
Ubiquitin
1
2008
70
0.070
Why?
Expressed Sequence Tags
1
2007
6
0.070
Why?
Diagnostic Imaging
1
2009
176
0.070
Why?
Infusion Pumps
1
1987
12
0.070
Why?
Fluorescent Antibody Technique
1
2007
109
0.070
Why?
Microdissection
1
2007
20
0.070
Why?
Models, Biological
2
2008
737
0.070
Why?
Precancerous Conditions
2
2005
87
0.060
Why?
Lasers
1
2007
64
0.060
Why?
MutS Homolog 2 Protein
5
2007
12
0.060
Why?
Stromal Cells
1
2007
77
0.060
Why?
Aorta
3
2005
172
0.060
Why?
Organ Specificity
2
2018
115
0.060
Why?
Pelvic Floor
1
2007
53
0.060
Why?
Codon
2
2003
42
0.060
Why?
Neutropenia
1
2007
113
0.060
Why?
Recombinant Proteins
1
2008
489
0.060
Why?
RNA, Double-Stranded
1
2006
23
0.060
Why?
Polymorphism, Single-Stranded Conformational
6
2003
18
0.060
Why?
Tissue Fixation
1
2006
35
0.060
Why?
Pulmonary Embolism
1
1987
83
0.060
Why?
Intestinal Perforation
2
2006
24
0.060
Why?
Head and Neck Neoplasms
2
2016
292
0.060
Why?
Protein Kinases
1
2006
72
0.060
Why?
Tosyl Compounds
1
2025
2
0.060
Why?
Leuprolide
1
2025
3
0.060
Why?
Specimen Handling
1
2006
63
0.060
Why?
Aromatase Inhibitors
1
2025
16
0.060
Why?
Anilides
1
2025
20
0.060
Why?
Chromosomes, Artificial, Yeast
3
2000
6
0.060
Why?
Nitriles
1
2025
55
0.060
Why?
Endometrial Hyperplasia
2
2002
14
0.060
Why?
Abdomen
1
2006
71
0.060
Why?
Proportional Hazards Models
4
2010
445
0.060
Why?
Papillomavirus Vaccines
1
2006
74
0.060
Why?
Neovascularization, Pathologic
1
2006
158
0.060
Why?
Recurrence
4
2010
694
0.060
Why?
Terminal Care
1
2005
37
0.050
Why?
Probability
4
2007
171
0.050
Why?
Dibenzocycloheptenes
1
2004
1
0.050
Why?
Chromatin
1
2026
145
0.050
Why?
Radiation-Sensitizing Agents
1
2005
50
0.050
Why?
Cell Adhesion Molecules
1
2005
88
0.050
Why?
Quinolines
1
2004
44
0.050
Why?
Male
11
2018
27444
0.050
Why?
High-Throughput Nucleotide Sequencing
1
2026
181
0.050
Why?
Tumor Suppressor Protein p53
1
2006
228
0.050
Why?
Amyloid
1
2004
36
0.050
Why?
Tissue Distribution
1
2004
174
0.050
Why?
Genes, Viral
1
2003
38
0.050
Why?
Enzyme-Linked Immunosorbent Assay
1
2004
233
0.050
Why?
Lactones
1
2003
25
0.050
Why?
Abdomen, Acute
1
2003
6
0.050
Why?
Biopsy, Needle
4
2006
181
0.050
Why?
Methylenetetrahydrofolate Reductase (NADPH2)
1
2003
58
0.050
Why?
Thrombospondins
1
2003
10
0.050
Why?
RNA, Viral
2
2016
123
0.050
Why?
Obesity, Morbid
1
2004
86
0.050
Why?
Pyrimidinones
1
2023
19
0.050
Why?
Clinical Competence
1
2006
406
0.050
Why?
Neoplasms, Second Primary
1
2004
75
0.050
Why?
Fibroma
1
2003
41
0.050
Why?
Radiotherapy, Adjuvant
3
2010
65
0.050
Why?
Congenital Abnormalities
1
2004
118
0.050
Why?
Uterine Hemorrhage
1
2002
7
0.050
Why?
Age of Onset
2
2004
109
0.050
Why?
Chromatography, High Pressure Liquid
1
2003
333
0.050
Why?
PTEN Phosphohydrolase
2
2019
55
0.050
Why?
Pneumatosis Cystoides Intestinalis
1
2002
7
0.050
Why?
DNA, Ribosomal
1
2002
26
0.050
Why?
Blood Transfusion, Autologous
1
2002
4
0.050
Why?
Pregnancy
3
2020
2610
0.050
Why?
Blood Donors
1
2002
21
0.050
Why?
Genital Diseases, Female
1
2002
18
0.050
Why?
Acridines
1
2002
4
0.040
Why?
Postmenopause
1
2002
85
0.040
Why?
Medical History Taking
1
2002
47
0.040
Why?
Medical Records
1
2002
85
0.040
Why?
Complementary Therapies
1
2002
23
0.040
Why?
Family Health
1
2002
78
0.040
Why?
AU Rich Elements
1
2021
2
0.040
Why?
Peptide Chain Initiation, Translational
1
2021
15
0.040
Why?
Cytokine Receptor gp130
1
2021
13
0.040
Why?
RNA Stability
1
2021
29
0.040
Why?
3' Untranslated Regions
1
2021
55
0.040
Why?
Receptors, Transforming Growth Factor beta
1
2001
29
0.040
Why?
Lymphatic Irradiation
1
2001
1
0.040
Why?
Internship and Residency
1
2006
439
0.040
Why?
Blotting, Northern
2
2001
106
0.040
Why?
Prostaglandin-Endoperoxide Synthases
1
2001
25
0.040
Why?
Diet Records
1
2001
19
0.040
Why?
Blotting, Southern
3
2002
40
0.040
Why?
Xenograft Model Antitumor Assays
1
2021
228
0.040
Why?
Catheterization, Central Venous
1
2001
80
0.040
Why?
Equipment Design
1
2001
290
0.040
Why?
Blood Vessels
1
2001
73
0.040
Why?
Phosphoric Monoester Hydrolases
1
2000
25
0.040
Why?
Uganda
1
2020
38
0.040
Why?
Logistic Models
2
2017
947
0.040
Why?
Isoenzymes
1
2001
165
0.040
Why?
Nutrition Assessment
1
2001
67
0.040
Why?
Risk Management
1
2000
31
0.040
Why?
Quality Improvement
1
2022
230
0.040
Why?
Incidence
3
2007
1085
0.040
Why?
Physical Chromosome Mapping
1
2000
7
0.040
Why?
Patient Discharge
1
2022
325
0.040
Why?
Dietary Fats
1
2001
133
0.040
Why?
beta Karyopherins
1
2019
4
0.040
Why?
Interviews as Topic
1
2001
280
0.040
Why?
Cell Survival
1
2021
600
0.040
Why?
Acid Anhydride Hydrolases
1
1999
14
0.040
Why?
DNA Repair Enzymes
1
1999
44
0.040
Why?
Adenosine Triphosphatases
1
1999
92
0.040
Why?
Cell Nucleus
1
2019
187
0.040
Why?
Regression Analysis
3
2006
391
0.040
Why?
Cross-Sectional Studies
1
2024
1723
0.040
Why?
Coloring Agents
1
2019
65
0.040
Why?
Molecular Targeted Therapy
1
2019
138
0.040
Why?
Pregnancy Outcome
1
2020
231
0.040
Why?
Chromosomes, Human, Pair 10
1
1998
4
0.040
Why?
Gene Dosage
1
2018
76
0.030
Why?
Th1-Th2 Balance
1
2018
2
0.030
Why?
Histone Demethylases
1
2018
22
0.030
Why?
Estradiol
1
2019
215
0.030
Why?
Leptin
1
2019
151
0.030
Why?
Databases, Genetic
1
2018
82
0.030
Why?
Major Histocompatibility Complex
1
2017
13
0.030
Why?
Epithelial-Mesenchymal Transition
1
2018
56
0.030
Why?
Genotyping Techniques
1
2017
19
0.030
Why?
Child
4
2018
7384
0.030
Why?
Time Factors
4
2010
2992
0.030
Why?
Chemokines
1
2017
78
0.030
Why?
Mass Screening
1
2000
362
0.030
Why?
Receptors, Collagen
1
1997
3
0.030
Why?
Interferon-gamma
1
2018
174
0.030
Why?
Receptors, Fibronectin
1
1997
5
0.030
Why?
Coculture Techniques
1
2017
146
0.030
Why?
Transforming Growth Factor beta
1
2018
136
0.030
Why?
Integrins
1
1997
34
0.030
Why?
Chemotherapy, Adjuvant
2
2010
122
0.030
Why?
Quality-Adjusted Life Years
2
2010
67
0.030
Why?
Diet, High-Fat
1
2019
243
0.030
Why?
Epithelial Cells
2
2006
218
0.030
Why?
Hepatitis Viruses
1
2016
2
0.030
Why?
Longitudinal Studies
1
2019
774
0.030
Why?
Herpesviridae
1
2016
19
0.030
Why?
Host-Pathogen Interactions
1
2017
135
0.030
Why?
Viruses
1
2016
24
0.030
Why?
Mice, Transgenic
1
2017
561
0.030
Why?
Pilot Projects
3
2004
727
0.030
Why?
Gastrointestinal Neoplasms
1
2016
44
0.030
Why?
Cost-Benefit Analysis
2
2010
274
0.030
Why?
DNA Replication
1
1997
161
0.030
Why?
Baths
1
1995
5
0.030
Why?
Plasmids
2
2001
165
0.030
Why?
Sequence Analysis, RNA
1
2016
97
0.030
Why?
Central Nervous System Neoplasms
1
2016
69
0.030
Why?
Fibroblasts
1
2017
363
0.030
Why?
Electrosurgery
1
1995
10
0.030
Why?
Macrophages
1
2018
380
0.030
Why?
Prostatic Neoplasms
1
1998
401
0.030
Why?
CpG Islands
2
2008
114
0.030
Why?
DNA Probes, HPV
2
1991
3
0.030
Why?
Computational Biology
1
2016
209
0.030
Why?
Cytokines
1
2017
627
0.030
Why?
Arteries
1
1995
93
0.030
Why?
Multivariate Analysis
2
2009
598
0.030
Why?
Class I Phosphatidylinositol 3-Kinases
1
2014
20
0.030
Why?
Treatment Failure
2
2008
119
0.030
Why?
Missouri
2
2006
67
0.030
Why?
Dementia
1
1995
141
0.030
Why?
Organs at Risk
1
2014
71
0.030
Why?
Inclusion Bodies
1
1993
17
0.020
Why?
Cell Division
2
1994
289
0.020
Why?
Parathyroid Hormone-Related Protein
1
1993
23
0.020
Why?
Cell Death
1
2014
171
0.020
Why?
Imaging, Three-Dimensional
1
2014
145
0.020
Why?
Cholera Toxin
1
1993
15
0.020
Why?
Cholera
1
1993
2
0.020
Why?
Risk
2
2004
306
0.020
Why?
Skin Physiological Phenomena
1
1992
16
0.020
Why?
Guinea Pigs
1
1992
75
0.020
Why?
Pelvis
2
2004
66
0.020
Why?
Epidermis
1
1992
32
0.020
Why?
Pedigree
2
2004
128
0.020
Why?
Deoxyglucose
1
2012
35
0.020
Why?
Colectomy
1
1992
36
0.020
Why?
Regeneration
1
1992
83
0.020
Why?
Computer Simulation
1
2012
290
0.020
Why?
Amino Acid Sequence
2
2003
563
0.020
Why?
Sequence Deletion
2
2003
69
0.020
Why?
Premenopause
1
2010
28
0.020
Why?
Staurosporine
1
2010
10
0.020
Why?
Anastomosis, Surgical
1
1990
69
0.020
Why?
Proto-Oncogene Proteins p21(ras)
2
2001
69
0.020
Why?
Remission Induction
1
2010
222
0.020
Why?
Molecular Weight
1
1990
77
0.020
Why?
ras Proteins
2
2001
64
0.020
Why?
Cicatrix
1
1990
43
0.020
Why?
Staining and Labeling
1
1990
94
0.020
Why?
Hemoglobins
1
1990
114
0.020
Why?
Chi-Square Distribution
1
2010
291
0.020
Why?
Fetus
1
1990
191
0.020
Why?
Perioperative Care
1
2009
44
0.020
Why?
Urinary Incontinence
1
2009
40
0.020
Why?
Gene Knockdown Techniques
1
2009
109
0.020
Why?
Organoplatinum Compounds
1
2008
15
0.020
Why?
Vinblastine
1
2008
22
0.020
Why?
Life Style
1
2009
150
0.020
Why?
Dose-Response Relationship, Radiation
1
2008
187
0.020
Why?
Emotions
1
2009
177
0.020
Why?
Cell Line
1
1990
1016
0.020
Why?
Cadherins
1
2007
62
0.020
Why?
Demography
1
2007
91
0.020
Why?
Intracellular Signaling Peptides and Proteins
1
2008
136
0.020
Why?
Skin
1
1990
420
0.020
Why?
Cytoplasmic Structures
1
2006
1
0.020
Why?
DNA Mismatch Repair
1
2006
18
0.020
Why?
Tissue Embedding
1
2006
1
0.020
Why?
Waxes
1
2006
2
0.020
Why?
NIH 3T3 Cells
1
2006
52
0.020
Why?
Immunoenzyme Techniques
2
2001
134
0.020
Why?
Eukaryotic Initiation Factor-2
1
2006
18
0.020
Why?
Tomography Scanners, X-Ray Computed
1
2006
11
0.020
Why?
Neoplasm, Residual
1
2007
171
0.020
Why?
Chromosomal Instability
1
2006
16
0.020
Why?
Analysis of Variance
1
2007
547
0.010
Why?
Cryopreservation
1
2006
41
0.010
Why?
Gene Expression
1
2008
618
0.010
Why?
Transfection
1
2006
359
0.010
Why?
Mutation, Missense
1
2006
110
0.010
Why?
Gynecology
1
2006
52
0.010
Why?
Early Diagnosis
1
2006
84
0.010
Why?
Nurse Practitioners
1
2006
43
0.010
Why?
Medical Futility
1
2005
8
0.010
Why?
Ovarian Cysts
1
2005
3
0.010
Why?
Sarcoma, Endometrial Stromal
1
2005
1
0.010
Why?
Triage
1
2006
65
0.010
Why?
Cyclophosphamide
1
2006
178
0.010
Why?
Leiomyosarcoma
1
2005
22
0.010
Why?
Hospice Care
1
2005
17
0.010
Why?
Cytodiagnosis
1
2005
42
0.010
Why?
Phosphorylation
1
2006
533
0.010
Why?
Obstetrics
1
2006
87
0.010
Why?
Health Services
1
2005
71
0.010
Why?
Lymphatic System
1
2004
13
0.010
Why?
Penetrance
1
2004
7
0.010
Why?
Microscopy, Electron, Transmission
1
2004
68
0.010
Why?
Area Under Curve
1
2004
185
0.010
Why?
Calcification, Physiologic
1
2004
42
0.010
Why?
Ethanol
1
2006
338
0.010
Why?
Laparotomy
1
2004
37
0.010
Why?
Bryostatins
1
2003
1
0.010
Why?
Macrolides
1
2003
17
0.010
Why?
Genomic Instability
1
2004
88
0.010
Why?
Tamoxifen
1
2004
60
0.010
Why?
Thrombospondin 1
1
2003
9
0.010
Why?
Genes, p16
1
2003
9
0.010
Why?
Palliative Care
1
2005
195
0.010
Why?
Codon, Terminator
1
2003
8
0.010
Why?
Confidence Intervals
1
2003
158
0.010
Why?
Administration, Oral
1
2004
456
0.010
Why?
Frameshift Mutation
1
2003
18
0.010
Why?
Liposomes
1
2003
55
0.010
Why?
Mutagenesis, Insertional
1
2003
24
0.010
Why?
Body Weight
1
2005
524
0.010
Why?
Cytoskeletal Proteins
1
2003
46
0.010
Why?
Physicians
1
2006
242
0.010
Why?
DNA Transposable Elements
1
2003
107
0.010
Why?
Prevalence
1
2006
1034
0.010
Why?
Reference Values
1
2003
311
0.010
Why?
beta Catenin
1
2003
107
0.010
Why?
Retinoblastoma-Like Protein p130
1
2002
8
0.010
Why?
Retinoblastoma Protein
1
2002
19
0.010
Why?
Ifosfamide
1
2002
9
0.010
Why?
Documentation
1
2002
33
0.010
Why?
Trans-Activators
1
2003
139
0.010
Why?
Bleomycin
1
2002
38
0.010
Why?
Hospitals, University
1
2002
75
0.010
Why?
Antineoplastic Agents, Alkylating
1
2002
78
0.010
Why?
Equipment Failure
1
2001
64
0.010
Why?
Age Distribution
1
2002
175
0.010
Why?
Statistics, Nonparametric
1
2002
198
0.010
Why?
Nucleic Acid Hybridization
2
1991
53
0.010
Why?
Antibiotics, Antineoplastic
1
2002
84
0.010
Why?
Carcinoma, Small Cell
1
2001
26
0.010
Why?
Radiography
1
2002
476
0.010
Why?
Genes, erbB-1
1
2001
9
0.010
Why?
Outpatients
1
2002
131
0.010
Why?
Hospitalization
1
2005
749
0.010
Why?
DNA
1
2004
535
0.010
Why?
Repetitive Sequences, Nucleic Acid
1
2000
86
0.010
Why?
Mitogen-Activated Protein Kinases
1
2001
152
0.010
Why?
Genetic Linkage
1
2000
25
0.010
Why?
Chromosomes, Human, Pair 2
1
2000
25
0.010
Why?
Morbidity
1
2000
132
0.010
Why?
Blotting, Western
1
2001
587
0.010
Why?
Gene Deletion
1
2000
279
0.010
Why?
Carcinoma, Non-Small-Cell Lung
1
2001
175
0.010
Why?
Chromosomes, Bacterial
1
1998
5
0.010
Why?
Cloning, Molecular
1
1998
175
0.010
Why?
Infant
1
2006
3808
0.010
Why?
Child, Preschool
1
2006
4164
0.010
Why?
Drug Resistance, Multiple
1
1997
25
0.010
Why?
Antineoplastic Agents, Phytogenic
1
1997
71
0.010
Why?
Gene Frequency
1
1997
97
0.010
Why?
United States
1
2007
5413
0.010
Why?
Hygiene
1
1995
11
0.010
Why?
Guidelines as Topic
1
1995
111
0.010
Why?
Dimethyl Sulfoxide
1
1994
12
0.010
Why?
Glycerol
1
1994
19
0.010
Why?
Ambulatory Surgical Procedures
1
1995
54
0.010
Why?
Drug Carriers
1
1994
68
0.010
Why?
Drug Screening Assays, Antitumor
1
1994
136
0.010
Why?
Cell Cycle
1
1994
237
0.010
Why?
H-2 Antigens
1
1993
3
0.010
Why?
Cell Line, Transformed
1
1993
73
0.010
Why?
Caregivers
1
1995
247
0.010
Why?
Mice, Inbred Strains
1
1993
163
0.010
Why?
Retroperitoneal Space
1
1991
26
0.010
Why?
Disease Models, Animal
1
1993
1517
0.000
Why?
Rader's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description